Antineoplastics

Antineoplastics

Agents that inhibit or prevent the development, maturation, and proliferation of malignant cells.
References in periodicals archive ?
For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers.
The global cancer market is becoming increasingly competitive, with two therapeutic classes namely antineoplastics and cytostatic hormonal treatments dominating this sector.
The global cancer market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating this sector.
1 Sales Forecast for Traditional Antineoplastics, 2010-2025
The paper, titled "A Comparison of Structure-Activity Relationships between Spermidine and Spermine Analogue Antineoplastics," by Dr.
The project currently involves such modification in the area of antineoplastics and antibiotics.
Lassus M, Scott D, and Leyland-Jones B: Allergic reactions associated with cremophor containing antineoplastics.
Also, our study's definition of exposure was broad: in addition to those directly contacting antineoplastics during their preparation, administration, and cleanup, we counted workers with potential for contact with contaminated work surfaces.
Other new antineoplastics are the antiandrogen enzalutamide (Xtandi; prostate cancer but could be used for other cancers), the proteasome inhibitor carfilzomib (Kyprolis; multiple myeloma), and the protein synthesis inhibitor omacetaxine (Synribo; leukemia).
Interactions involving anesthesia, the specialist use of multiple antiretrovirals, the specialist use of multiple antineoplastics or intravenous antineoplastics, and non-interactions are mostly omitted.
Largely used to treat cancer, antineoplastics represented the fourth-leading specialty-drug therapy class in 2005.